Urinary Tract Infections in Kidney Transplant Recipients
URIKIT
1 other identifier
observational
120
1 country
1
Brief Summary
The purpose of this study is to better estimate the prevalence of urinary tract infections (UTI) in kidney transplant (KIT) recipients, and especially multidrug resistant (MDR) bacteria. KIT recipients have a higher risk of UTI over the 6 first months following the transplantation. Urine culture was done in a city lab or at hospital. Current data on bacteriuria and candiduria lead mostly to hospital data that are incomplete..
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started May 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 4, 2017
CompletedFirst Submitted
Initial submission to the registry
June 23, 2017
CompletedFirst Posted
Study publicly available on registry
July 7, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 4, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 4, 2024
CompletedApril 14, 2021
April 1, 2021
5 years
June 23, 2017
April 13, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Assessment of UTI due to MDR bacteria
Proportion of MDR bacteria compared to other bacteria found in urinalysis of symptomatic KIT patients
Day 0 to 2 years
Secondary Outcomes (9)
Epidemiology of UTI in KIT recipients
Day 0 to 2 years
Risk factors for MDR UTI
Day 0 to 2 years
Carbapenem use to treat UTI
Day 0 to 2 years
Coherence between antibiotic protocol and treatment received to treat UTI
Day 0 to 2 years
UTI relapse frequency
Day 0 to 2 years
- +4 more secondary outcomes
Interventions
No intervention
Eligibility Criteria
Male and female
You may qualify if:
- Age ≥ 18 year-old
- Kidney transplanted for less than 5 years
- First symptomatic episode of UTI with bacteria or yeast
- To have a health insurance
You may not qualify if:
- Asymptomatic bacteriuria or candiduria
- Protected people
- Pregnant women -\> 2 bacteria in the urinalysis without external or internal urinary catheter
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Poitiers University Hospitallead
- Merck Sharp & Dohme LLCcollaborator
Study Sites (1)
CHU de Poitiers
Poitiers, 86000, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Antoine THIERRY, PHD
Poitiers University Hospital
- STUDY DIRECTOR
Blandine RAMMAERT
Poitiers University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2017
First Posted
July 7, 2017
Study Start
May 4, 2017
Primary Completion
May 4, 2022
Study Completion
May 4, 2024
Last Updated
April 14, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share
No plan will be sharing with others researchers